Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: Antimicrobial non-susceptibility among 108717 clinical isolates from primary, secondary and tertiary care patients in London

Luke S.P. Moore, Rachel Freeman, Mark J. Gilchrist, Myriam Gharbi, Eimear T. Brannigan, Hugo Donaldson, David Livermore, Alison H. Holmes

Research output: Contribution to journalArticlepeer-review

24 Citations (Scopus)

Abstract

Objectives:We examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community. Methods: Laboratory and pharmacy information management systems were interrogated, with antimicrobial use and susceptibilities analysed between hospitals, within hospitals and over time. Results: A total of 108717 isolates from 71687 patients were identified, with significant differences (at P < 0.05) in antimicrobial susceptibility between and within hospitals. Across the 4 years, rates of ESBL-/AmpC-producing Enterobacteriaceae ranged from 6.4% to 10.7% among community isolates, 17.8% to 26.9% at ward level and 25.2% to 52.5% in critical care. Significant variations were also demonstrated in glycopeptide-resistant enterococci (ward level 6.2%-17.4%; critical care 21.9%-56.3%), MRSA (ward level 18.5%-38.2%; critical care 12.5%- 47.9%) and carbapenem-resistant Pseudomonas spp. (ward level 8.3%-16.9%; critical care 19.9%-53.7%). Few instances of persistently higher resistance were seen between the hospitals in equivalent cohorts, despite persistently higher antimicrobial use in Hospital 1 than Hospital 2. We found significant fluctuations in non-susceptibility year on year across the cohorts, but with few persistent trends. Conclusions: The marked heterogeneity of antimicrobial susceptibilities between hospitals, within hospitals and over time demands detailed, standardized surveillance and appropriate benchmarking to identify possible drivers and effective interventions. Homogeneous antimicrobial policies are unlikely to continue to be suitable as individual hospitals join hospital networks, and policies should be tailored to local resistance rates, at least at the hospital level, and possibly with finer resolution, particularly for critical care.

Original languageEnglish
Pages (from-to)3409-3422
Number of pages14
JournalJournal of Antimicrobial Chemotherapy
Volume69
Issue number12
DOIs
Publication statusPublished - 1 Dec 2014

Keywords

  • Antibiograms
  • Antimicrobial stewardship
  • Healthcare-associated infections
  • Multidrug-resistant organisms

Fingerprint

Dive into the research topics of 'Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: Antimicrobial non-susceptibility among 108717 clinical isolates from primary, secondary and tertiary care patients in London'. Together they form a unique fingerprint.

Cite this